Twist Bioscience Corp (TWST) Stock Price, Quote & News

Company Profile

Twist Bioscience Corporation manufactures and sells synthetic DNA-based products. The company offers synthetic genes and gene fragments used in product development for therapeutics, diagnostics, chemicals/materials, food/agriculture, data storage, and various applications within academic research by biotech, pharma, industrial chemical, and agricultural companies, as well as academic labs; Oligo pools used in targeted NGS, CRISPR gene editing, mutagenesis experiments, DNA origami, DNA computing,...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 800 719 0671

Website: www.twistbioscience.com

Address:

681 Gateway Boulevard, South San Francisco, United States

degeneratetrader23 Oct. 4 at 5:34 PM

$TWST gravestone doji. 68 rsi. Gimme 25!

0 · Reply

JFDI Oct. 3 at 2:12 PM

$TWST blast from the past

0 · Reply

G_R_ Oct. 2 at 7:29 PM

$CRSP $EDIT $TWST Hello there old friends.

0 · Reply

JarvisFlow Oct. 2 at 1:21 PM

Barclays has updated their rating for Twist Bioscience ( $TWST ) to Overweight with a price target of 40.

0 · Reply

rooneyray Oct. 1 at 2:59 PM

$MXCT $RGEN $TWST $CLPT This entire sector is undervalued. Let's go gang.

0 · Reply

highnihilism Oct. 1 at 8:05 AM

0 · Reply

Night_Owl_Biotech Oct. 1 at 2:10 AM

The XBI was up 21% in Q32025. The attachment notes the change in share price during the quarter for all 33 commercial-stage oncology focused bios versus all 33 in non-oncology with market caps between $1.5 & $5.0B as of the end of the quarter. It is not a perfect comparison because there are way more commercial-stage non-oncology focused bios. Note exactly 2/3s in each peer group were higher in the quarter. $CHRS & VSTM were the 2 biggest winners in the quarter in oncology. $LQDA was the winner in non-oncology. $VCEL & $TWST were the 2 biggest losers in non-oncology. Interestingly, VCEL is still one the best performing stocks in the peer group since their first FDA approval. $PGEN was the best performing in commercial-stage bio up 156% (though new in the quarter). If anyone can tell us which peer group (oncology or non) to which PGEN belongs, we'd appreciate the perspective. We assume oncology but... This is for entertainment purposes only. This is not investment advice.

0 · Reply

LiquidThetaLEAPS Sep. 30 at 10:01 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $TWST Current Share Price: $27.28 Contracts: $TWST April 17, 2026 $28 Calls Scale in: $5.40- $6.60 Scale out: $8.40-$10.80 Can Easily Capture: 60% ROI Blended DTE: 200 Days | Join Elites here: https://liquidtheta.com/options

0 · Reply

Night_Owl_Biotech Sep. 29 at 4:47 PM

SNDX peaked at $17.04 on 9/5/2025. Since then the XBI is up 4% while SNDX is off 11.4%. We're scratching our heads because last week the NCCN recommended Revuforj for mNPM1 AML, before the actual PDUFA date. The attachment compares a pool of commercial-stage oncology focused bios versus non-oncology since 9/5/2025. This is not scientific but just an observation but 80% of the oncology focused bios are trading lower during this time while 60% of non-oncology are trading higher. It is not by any means perfect as we picked the 15 in each group more or less at random but their market caps relative to the peer groups as a whole were more or less in the same quintiles. $BCRX $TWST $AUPH $URGN $ZYME This is not investment advice.

0 · Reply

LiquidThetaLEAPS Sep. 29 at 7:22 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $TWST Current Share Price: $26.91 Contracts: $TWST April 17, 2026 $28 Calls Scale in: $5.00- $6.11 Scale out: $7.77-$9.99 Can Easily Capture: 60% ROI Blended DTE: 201 Days | Join Elites here: https://liquidtheta.com

0 · Reply

Twist Bioscience Announces Publication in Science Examining Biosecurity Screening Practices in AI-assisted Protein Design

Sep 3, 2025, 8:00 AM EDT - 4 weeks ago

Twist Bioscience to Present at Baird 2025 Global Healthcare Conference

Sep 2, 2025, 8:00 AM EDT - 4 weeks ago

Twist Bioscience Collaborates with Synthetic Design Lab

Aug 28, 2025, 6:20 AM EDT - 5 weeks ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL ILMN IONS MRNA

Aug 19, 2025, 8:00 AM EDT - 6 weeks ago

Twist Bioscience Launches Oncology DNA CGP Panel to Advance Precision Medicine with Customizable, Platform-Agnostic NGS Solution

Aug 12, 2025, 10:56 PM EDT - 7 weeks ago

Twist Bioscience: Headwinds Are Mounting

Aug 6, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience Appoints Trynka Shineman Blake to Board of Directors

Aug 4, 2025, 3:52 PM EDT - 2 months ago

Twist Bioscience Turns The Tide: Q3 Sales Jump, Beats Earnings

Aug 4, 2025, 11:06 AM EDT - 2 months ago

Twist Bioscience Corporation (TWST) Q3 2025 Earnings Call Transcript

Aug 4, 2025, 7:15 AM EDT - 2 months ago

Twist Bioscience Announces Fiscal 2025 Third Quarter Financial Results

Jul 31, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience Expands In Vivo Antibody Discovery Services with Launch of Humanized Transgenic Mouse Model

Jul 24, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Jul 15, 2025, 4:02 PM EDT - 2 months ago

Twist Bioscience: Still Not There Yet

Jul 14, 2025, 8:00 AM EDT - 2 months ago

Twist Bioscience to Report Fiscal 2025 Third Quarter Financial Results on Monday, August 4, 2025

Jul 7, 2025, 8:00 AM EDT - 3 months ago

Twist Bioscience Expands Express Delivery Turnaround Time to All Gene Fragments Regardless of Format

May 22, 2025, 8:00 AM EDT - 4 months ago

Twist Bioscience and Element Biosciences Expand Collaboration to Transform Next Generation Sequencing Workflows with Co-Developed End-to-End Solutions

May 15, 2025, 8:00 AM EDT - 5 months ago

Twist Bioscience to Present at William Blair 45th Annual Growth Stock Conference

May 8, 2025, 8:00 AM EDT - 5 months ago

Twist Bioscience and Ginkgo Bioworks Revise Collaboration

DNA

May 7, 2025, 2:18 AM EDT - 5 months ago

Twist Bioscience: Expansion Efforts Continue To Face Challenges

May 5, 2025, 11:41 AM EDT - 5 months ago

Twist Bioscience Corporation (TWST) Q2 2025 Earnings Call Transcript

May 5, 2025, 7:15 AM EDT - 5 months ago

Twist Bioscience Announces Fiscal 2025 Second Quarter Financial Results

May 5, 2025, 7:10 AM EDT - 5 months ago

Twist Bioscience Spins Out DNA Data Storage as Independent Company

May 1, 2025, 12:05 PM EDT - 5 months ago

Twist Bioscience Q2 Earnings Preview: Innovative Products, Not Enough Buyers

Apr 24, 2025, 8:00 AM EDT - 5 months ago

Twist Bioscience Expands Universal Adapter Portfolio with Launch of High Throughput UDI Adapter System

Mar 31, 2025, 8:00 AM EDT - 6 months ago

Twist Bioscience and Curio Genomics Collaborate to Accelerate and Streamline NGS Adoption in Agrigenomics

Mar 11, 2025, 7:30 AM EDT - 7 months ago

Twist Bioscience Offers Clonal Genes for Global Academic Researchers at Express Speed for No Extra Cost

Feb 25, 2025, 8:00 AM EST - 7 months ago

Twist Bioscience to Present at Upcoming Investor Conferences

Feb 19, 2025, 8:00 AM EST - 8 months ago

Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Feb 5, 2025, 11:30 PM EST - 8 months ago

Twist Bioscience: Valuation Is Weighing On The Stock

Feb 3, 2025, 10:55 AM EST - 8 months ago

Twist Bioscience Corporation (TWST) Q1 2025 Earnings Call Transcript

Feb 3, 2025, 7:15 AM EST - 8 months ago

Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

Jan 23, 2025, 10:35 AM EST - 9 months ago

Gene Synthesis Market Size to Surpass USD 9.54 Billion by 2033 | Straits Research

Jan 22, 2025, 8:00 AM EST - 9 months ago

Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025

Dec 19, 2024, 8:00 AM EST - 10 months ago

Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference

Nov 29, 2024, 9:55 AM EST - 11 months ago

Twist Bioscience: Path To Profitability Beginning To Take Shape

Nov 18, 2024, 3:16 PM EST - 11 months ago

Twist Bioscience: A Post-Earnings Assessment

Nov 18, 2024, 12:17 PM EST - 11 months ago

Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps

Nov 18, 2024, 11:31 AM EST - 11 months ago

Twist Bioscience Corporation (TWST) Q4 2024 Earnings Call Transcript

Nov 18, 2024, 7:15 AM EST - 11 months ago

Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results

Nov 14, 2024, 8:00 AM EST - 11 months ago

Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference

Nov 8, 2024, 5:14 AM EST - 11 months ago

Twist Bioscience's Earnings Preview: Partnerships And Valuation Make It A 'Buy'

Oct 30, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics

Oct 24, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024

Oct 22, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash

XOMA

Oct 15, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer

Sep 12, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Achieves LEED Certification for Sustainable Operations and Maintenance

Sep 9, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Releases 2024 Corporate Responsibility Report and Quantifies Carbon Footprint of Oligo Manufacturing Process for NGS Target Enrichment Panels

Aug 27, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience to Present at Baird Global Healthcare Conference 2024

Aug 8, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience Expands Gene Offering With Long Gene Fragments up to 5.0kb

Aug 5, 2024, 8:00 AM EDT - 1 year ago

Twist Bioscience and bitBiome Announce Strategic Collaboration and First Offering to Deliver One-of-a-Kind Enzymes for Biocatalysis

degeneratetrader23 Oct. 4 at 5:34 PM

$TWST gravestone doji. 68 rsi. Gimme 25!

0 · Reply

JFDI Oct. 3 at 2:12 PM

$TWST blast from the past

0 · Reply

G_R_ Oct. 2 at 7:29 PM

$CRSP $EDIT $TWST Hello there old friends.

0 · Reply

JarvisFlow Oct. 2 at 1:21 PM

Barclays has updated their rating for Twist Bioscience ( $TWST ) to Overweight with a price target of 40.

0 · Reply

rooneyray Oct. 1 at 2:59 PM

$MXCT $RGEN $TWST $CLPT This entire sector is undervalued. Let's go gang.

0 · Reply

highnihilism Oct. 1 at 8:05 AM

0 · Reply

Night_Owl_Biotech Oct. 1 at 2:10 AM

0 · Reply

LiquidThetaLEAPS Sep. 30 at 10:01 PM

0 · Reply

Night_Owl_Biotech Sep. 29 at 4:47 PM

0 · Reply

LiquidThetaLEAPS Sep. 29 at 7:22 AM

0 · Reply

1AlwaysBull1 Sep. 28 at 5:55 PM

$TWST did some basic research on the company. First sight very interesting. However, What do you think on the Atlas thing? It seems like they took one of the most appealing side of the business- dna storage and gave it away quietly. Seems bad imo, are there long here? Are you ok with it?

0 · Reply

vision_and_motion91 Sep. 27 at 5:40 PM

$TWST Pinned charts across rooms are SHOT, heat map blinking, feels like volume avalanche loading for Monday open 📈

0 · Reply

JosephineCobb87 Sep. 27 at 5:21 PM

$TWST SHOT order books thin above trigger once bids step up the rip can be surprisingly quick to first target

0 · Reply

LiquidThetaLEAPS Sep. 27 at 4:35 PM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $TWST Current Share Price: $26.99 Contracts: $TWST April 17, 2026 $28 Calls Scale in: $4.77- $5.83 Scale out: $7.42-$9.54 Can Easily Capture: 60% ROI Blended DTE: 203 Days | Join Elites here: https://liquidtheta.com

0 · Reply

LiquidThetaLEAPS Sep. 26 at 5:34 AM

LiquidTheta® LEAPS LIVE Actionable Alert Asset: $TWST Current Share Price: $27.02 Contracts: $TWST April 17, 2026 $28 Calls Scale in: $5.24- $6.41 Scale out: $8.15-$10.48 Can Easily Capture: 60% ROI Blended DTE: 204 Days | Join Elites here: https://liquidtheta.com

0 · Reply

MoneyGroupLLC Sep. 23 at 3:38 AM

Enter: $TWST OCT 17 2025 $28 CALLS Buy in Price: $1.50 - $3.90 Take Profit: $1.77 Stop Bleeding: $1.32 ROI Potential: 18% Exit Within: 77 Minutes https://moneygroup.us/alerts

0 · Reply

solo_soul84 Sep. 17 at 12:46 PM

$TWST Soon 🚀 🚀 Let's go baby

0 · Reply

BillionerOfKing Sep. 17 at 12:12 PM

$TWST Current Stock Price: $27.08 Contracts to trade: $30 TWST Sep 19 2025 Call Entry: $0.05 Exit: $0.08 ROI: 79% Hold ~30 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts

0 · Reply

CajunMuffin Sep. 16 at 6:15 PM

Omg welp it has been a while since $TWST hasnt disappointed everyone that it feels weird when it goes up

0 · Reply

CajunMuffin Sep. 16 at 6:13 PM

I usually come here only to curse out $TWST and $TTD , but Twist is off the hook today. Not piece of shit $TTD lol

0 · Reply

highnihilism Sep. 16 at 3:03 PM

Biotech → $KRYS Krystal Biotech $NTRA Natera $MYGN Myriad Genetics $VIR Vir Biotechnology $TWST Twist Bioscience

0 · Reply

MoneyGroupLLC Sep. 13 at 7:07 PM

Enter: $TWST OCT 17 2025 $28 CALLS Buy in Price: $1.99 - $4.00 Take Profit: $2.23 Stop Bleeding: $1.75 ROI Potential: 12% Exit Within: 61 Minutes https://moneygroup.us/alerts

0 · Reply

Market Cap	1.88B
Revenue (ttm)	312.97M
Net Income (ttm)	-208.73M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.69%
Debt to Equity Ratio	0.03

Volume	1,965,800
Avg Vol	1,720,464
Day's Range	N/A - N/A
Shares Out	60.36M
Stochastic %K	70%
Beta	2.38
Analysts	Strong Sell
Price Target	$41.43